Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Akums Drugs and Pharmaceuticals Limited ( (IN:AKUMS) ).
Akums Drugs and Pharmaceuticals Limited has announced the incorporation of a wholly owned subsidiary in Malta, named Akums Healthcare Malta Private Limited. This strategic move is expected to enhance the company’s presence in the European market, potentially opening new avenues for growth and strengthening its international operations.
More about Akums Drugs and Pharmaceuticals Limited
Akums Drugs and Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the production and distribution of drugs and healthcare products. The company is known for its extensive range of pharmaceutical formulations and is a significant player in the healthcare market.
Average Trading Volume: 14,026
Technical Sentiment Signal: Strong Sell
Current Market Cap: 72.5B INR
See more insights into AKUMS stock on TipRanks’ Stock Analysis page.